These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9549352)

  • 21. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
    Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
    Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
    J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin.
    Omori N; Maruyama K; Jin G; Li F; Wang SJ; Hamakawa Y; Sato K; Nagano I; Shoji M; Abe K
    Neurol Res; 2003 Apr; 25(3):275-9. PubMed ID: 12739237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
    Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer.
    Paszko E; Vaz GM; Ehrhardt C; Senge MO
    Eur J Pharm Sci; 2013 Jan; 48(1-2):202-10. PubMed ID: 23159666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
    Visser CC; Stevanović S; Voorwinden LH; van Bloois L; Gaillard PJ; Danhof M; Crommelin DJ; de Boer AG
    Eur J Pharm Sci; 2005 Jun; 25(2-3):299-305. PubMed ID: 15911226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
    Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes.
    Derycke AS; De Witte PA
    Int J Oncol; 2002 Jan; 20(1):181-7. PubMed ID: 11743662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
    Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
    Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor.
    Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y
    Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
    Ho EA; Ramsay E; Ginj M; Anantha M; Bregman I; Sy J; Woo J; Osooly-Talesh M; Yapp DT; Bally MB
    J Pharm Sci; 2010 Jun; 99(6):2839-53. PubMed ID: 20091826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery.
    Wei W; Zhang X; Chen X; Zhou M; Xu R; Zhang X
    Nanoscale; 2016 Apr; 8(15):8118-25. PubMed ID: 27025546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
    Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
    Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
    Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
    J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes.
    Sadzuka Y; Kishi K; Hirota S; Sonobe T
    J Liposome Res; 2003 May; 13(2):157-72. PubMed ID: 12855110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.